Sotera Health Company IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Sotera Health Company | SHC - NASDAQ |
$20.00-$23.00 |
$23.00 |
$27.00 | 46.6 million | 11/20/2020 |
J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup, RBC Capital Markets |
Co-Manager(s): BNP PARIBAS, KeyBanc Capital Markets, Citizens Capital Markets, ING, Academy Securities, Loop Capital, Penserra Securities, Siebert Williams Shank, Tigress Financial Partners |
Health Care |
Filing(s): Terms Added 2020-11-12 Filed 2020-10-23
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Sotera Health Company, and our comprehensive analysis, click "Buy Market Research".
Sotera Health Company Quote & Chart - Click for current quote -
SHC
About Sotera Health Company (adapted from Sotera Health Company prospectus):
They serve their customers throughout their product lifecycles, from product design to manufacturing and delivery, helping to ensure the sterility, effectiveness and safety of their products for the end user.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SHC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved